Which benzodiazepines can be safely prescribed during pregnancy and while breastfeeding, and what are the recommended dosing and timing considerations?

Benzodiazepines During Pregnancy and Breastfeeding

Benzodiazepines should be avoided during pregnancy whenever possible due to increased miscarriage risk and potential fetal harm, but if absolutely necessary for severe psychiatric illness, use the shortest-acting agents at the lowest dose for the briefest duration; during breastfeeding, midazolam and lorazepam are the safest choices for single-dose use, while diazepam should be avoided due to significant milk transfer of its long-acting metabolite.

During Pregnancy

General Approach

All benzodiazepines carry risks during pregnancy. Recent evidence demonstrates that benzodiazepine use during pregnancy increases miscarriage risk (OR 1.69,95% CI 1.52-1.87), with this association persisting across multiple sensitivity analyses 1. This risk applies to all commonly used benzodiazepines, ranging from alprazolam (OR 1.39) to fludiazepam (OR 2.52) 1.

When Benzodiazepines Cannot Be Avoided

If psychiatric illness is severe enough that discontinuation poses greater risk than continuation:

• Avoid first trimester use entirely when possible, as this is the period of organogenesis 2, 3
• Use established agents with longer safety records: chlordiazepoxide appears safest based on available data 2
• Avoid alprazolam specifically - prudent to avoid during pregnancy 2
• Prescribe as monotherapy at the lowest effective dose 2
• Divide daily doses into 2-3 administrations to avoid high peak concentrations 2
• Use for shortest possible duration 2

Critical Timing Considerations

Late third trimester and labor exposure carries the highest neonatal risk 4, 5:

• Floppy infant syndrome (hypotonia, poor feeding, sedation)
• Neonatal withdrawal symptoms (apnea, cyanosis, impaired thermoregulation)
• Symptoms can persist for hours to months after birth 4
• Use lowest effective dose if required during delivery 5

Agents with Slower Placental Transfer

Oxazepam, lorazepam, nitrazepam, and flunitrazepam penetrate the placenta more slowly than diazepam, though clinical significance remains uncertain 5.

During Breastfeeding

Preferred Agents

Midazolam is the safest choice for breastfeeding mothers 6:

• Extensive first-pass metabolism results in low systemic bioavailability after oral doses
• Blood levels in infant after breastfeeding are expected to be low
• Breastfeeding can resume immediately after single dose once mother has recovered from the procedure

Lorazepam and temazepam are acceptable alternatives as shorter-acting benzodiazepines 6.

Agents to Avoid or Use with Extreme Caution

Diazepam should be avoided for routine use 6:

• Has active metabolite desmethyl-diazepam with prolonged half-life
• Transferred in breast milk at significant levels
• Can cause lethargy, sedation, and weight loss in infants 2
• May be considered only as one-off dose before a procedure 6

Evidence on Milk Transfer

Recent pharmacokinetic data demonstrates that for most benzodiazepines, milk-to-plasma ratios are <1 and remain constant over time 7. Relative infant doses (RID) are <10% for most agents (considered safe threshold), with only ethyl loflazepate slightly exceeding 10% 7. No abnormalities were found in breastfeeding infants whose mothers received these medications 7.

Specific agents studied with favorable profiles include: alprazolam, brotizolam, clonazepam, clotiazepam, etizolam, flunitrazepam, and lorazepam 7.

Practical Recommendations for Breastfeeding

• Single-dose use: Resume breastfeeding as soon as mother has recovered sufficiently (applies to midazolam, lorazepam, temazepam) 6
• Monitor infant for drowsiness, poor feeding, and sedation
• Avoid co-sleeping when taking benzodiazepines, as maternal responsiveness may be inhibited 6
• Premature infants are at higher risk and require more careful consideration 4

Common Pitfalls to Avoid

1. Don't assume all benzodiazepines are equivalent - pharmacokinetics vary significantly, particularly regarding active metabolites
2. Don't prescribe diazepam routinely during breastfeeding - its long-acting metabolite accumulates
3. Don't use high doses near delivery - risk of floppy infant syndrome is dose-dependent
4. Don't forget to counsel about infant monitoring - parents must know warning signs (excessive drowsiness, poor feeding, respiratory changes)
5. Don't overlook the untreated psychiatric illness risk - severe maternal illness also poses risks to mother and infant that must be weighed 3